1. 61MO IMscin001 (part 2: randomized phase III): Pharmacokinetics (PK), efficacy and safety of atezolizumab (atezo) subcutaneous (SC) vs intravenous (IV) in previously treated locally advanced or metastatic non-small cell lung cancer (NSCLC). (December 2022) Authors: Burotto, M.; Zvirbule, Z.; Mochalova, A.; Runglodvatana, Y.; Herraez Baranda, L.A.; Liu, S.; Chan, P.; Shearer-Kang, E.; Shivhare, M.; Tosti, N.; Zanghi, J.; Leutgeb, B.; Felip, E. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. EP-1155: Outcomes of breast cancer patients older than 80 years treated with adjuvant radiotherapy. (May 2017) Authors: Barrientos, R.; Frelinghuysen, M.; Burotto, M. Journal: Radiotherapy and oncology Issue: Volume 123:(2017:May)Supplement 1 Page Start: S628 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Outcomes of breast cancer patients older than 80 years treated with adjuvant radiotherapy. (February 2017) Authors: Barrientos, R.; Frelinghuysen, M.; Burotto, M. Journal: European journal of cancer Issue: Volume 72(2017)Supplement 1 Page Start: S27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗